Home › Funds › Redmile Group, LLC › RGNX
Redmile Group, LLC position in RGNX
REGENXBIO INC · Health Care
Redmile Group, LLC reported holding 4,368,804 shares of RGNX (REGENXBIO INC) in its Q2 2026 13F filing — a position valued at US$52.3M, representing 3.51% of its reported portfolio and ranking #8 among its reported holdings. Redmile Group, LLC has disclosed RGNX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Redmile Group, LLC's RGNX position evolved
Redmile Group, LLC first disclosed a stake in RGNX in Q3 2023 at 2,574,042 shares (US$42.4M). The position peaked in Q1 2024 at 4,551,556 shares, worth US$95.9M. Across 12 filings, Redmile Group, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 4,368,804 shares valued at US$52.3M. Notable position changes include a 46% increase in Q4 2023 (shares rose 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.57M | $42.37M | New |
| Q4 2023 | 3.76M | $67.50M | Add |
| Q1 2024 | 4.55M | $95.90M | Add |
| Q2 2024 | 4.57M | $53.47M | Hold |
| Q3 2024 | 4.89M | $51.33M | Add |
| Q4 2024 | 4.79M | $37.06M | Reduce |
| Q1 2025 | 4.79M | $34.28M | Hold |
| Q2 2025 | 4.78M | $39.21M | Hold |
| Q3 2025 | 4.69M | $45.29M | Reduce |
| Q4 2025 | 4.37M | $62.91M | Reduce |
| Q1 2026 | 4.37M | $36.61M | Hold |
| Q2 2026 | 4.37M | $52.34M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RGNX and 13F data
RGNX (REGENXBIO INC) is a Health Care company. 33 other funds we track also report a position in RGNX — the largest reported positions include 22NW, LP (US$5.9M), Pale Fire Capital SE (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RGNX
- 22NW, LP 492.76K sh · $5.90M · Q2 2026
- Pale Fire Capital SE 466.21K sh · $5.59M · Q2 2026
More on Redmile Group, LLC
FAQ
How long has Redmile Group, LLC held RGNX?
Redmile Group, LLC has disclosed RGNX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Redmile Group, LLC's current position in RGNX?
As of Q2 2026, Redmile Group, LLC holds 4.37M shares of RGNX (REGENXBIO INC), valued at $52.34M, representing 3.51% of its reported portfolio and ranking #8.
Has Redmile Group, LLC been buying or selling RGNX?
In the latest 13F filing (Q2 2026), Redmile Group, LLC held unchanged its position in RGNX. The position peaked in Q1 2024 at 4.55M shares.
Which other funds hold RGNX?
Other major institutional holders of RGNX include 22NW, LP, Pale Fire Capital SE, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.